# Vanda Pharmaceuticals Inc.: Form 8-K, filed Mar 10, 2026

- Company: [Vanda Pharmaceuticals Inc.](/companies/vnda.md) (CIK 1347178)
- Form: 8-K
- Filed: 2026-03-10
- Accepted by EDGAR: Mar 10, 2026, 16:47 ET
- Period: 2026-03-10
- Accession: 0001628280-26-016516
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1347178/000162828026016516/vnda-20260310.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1347178/000162828026016516/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1347178/000162828026016516/vnda-20260310.htm

Filed Mar 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-016516. Last ingested by Listed: Oct 29, 2026, 08:08 ET. No prices; not investment advice.